Evolutionary Genomics: Funding, Investors & Team (Sep 2026)
Evolutionary Genomics (EG) is a unique biotechnology company that is changing how relevant gene/target discovery and validation is performed during the post-genomics era. The company's proprietary Adapted Traits platform sifts through vast amounts of genomic data to identify only those genes that have a high likelihood of commercial value for downstream validation. EG applies this platform to identify high-value targets for drug-discovery or genes for use in natural crop yield or pest/disease-resistance enhancement.
Evolutionary Genomics has raised $1.0M across 1 funding round on record, the most recent a Post-IPO Equity of $1.0M announced in May 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Evolutionary Genomics Company Profile and Key Stats
Latest funding round on record: May 2022.
Evolutionary Genomics Funding Rounds
Evolutionary Genomics Founders and Leadership Team
Contact details for the Evolutionary Genomics team: 1 of 1 has an email address on file.
Start 14-day free trial →Evolutionary Genomics Funding Compared to Other Biotechnology Startups
Evolutionary Genomics' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Evolutionary Genomics in Biotechnology and Lafayette
Companies Similar to Evolutionary Genomics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Evolutionary Genomics Funding FAQs
What does Evolutionary Genomics do?
Evolutionary Genomics (EG) is a unique biotechnology company that is changing how relevant gene/target discovery and validation is performed during the post-genomics era. The company's proprietary Adapted Traits platform sifts through vast amounts of genomic data to identify only those genes that have a high likelihood of commercial value for downstream validation. EG applies this platform to identify high-value targets for drug-discovery or genes for use in natural crop yield or pest/disease-resistance enhancement.
How much funding has Evolutionary Genomics raised?
Evolutionary Genomics has raised $1.0M across 1 round on record. The most recent is a Post-IPO Equity of $1.0M announced in May 2022.
When did Evolutionary Genomics last raise funding?
Evolutionary Genomics' most recent funding round on record is a Post-IPO Equity of $1.0M, announced in May 2022.
Who is the CEO of Evolutionary Genomics?
Steve Warnecke is listed as CEO at Evolutionary Genomics.
Where is Evolutionary Genomics headquartered?
Evolutionary Genomics is based in Lafayette, Colorado, United States.
How many employees does Evolutionary Genomics have?
Evolutionary Genomics is in the 1-10 employee band.
How does Evolutionary Genomics' funding compare to other Biotechnology startups?
Evolutionary Genomics' latest round of $1.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Evolutionary Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evolutionary Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.